Cystoscopes Market is Expected to Hit US$ 612.4 Million By

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
91
Cystoscopes Market is Expected to Hit US$ 612.4 Million By 2026: Credence Research

SAN JOSE, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- The latest market report published by Credence Research, Inc. “ Cystoscopes Market Growth, Future Prospects, and Competitive Analysis, 2018 -2026 ” the global cystoscopes market will be valued at US$ 612.4 Mn by 2026.

Market Insights

The global cystoscopes market accounted to a market value of US$ 334.9 Mn in 2017 and expected to grow with a CAGR of 6.9% during the forecast period from 2018 to 2026. Minimal invasion technique, growing research activities in enhancing cystoscope technology, reduced procedural time, and growing healthcare infrastructure primarily catalyze the overall cystoscopes market growth. As per the American Cancer Society, around 81,190 new cases of bladder cancer estimated to be diagnosed in 2018. According to a research study by Justin B. Ziemba and Brain R. Matlaga published in 2017 (Epidemiology and economics of nephrolithiasis; Investig Clin Urol.2017 Sep;58 (5):299-306), nephrolithiasis (kidney stones) was prevalent in 10.6% of men and 7.1% of women in the U.S. Blue Light Cystoscopy (BLC) with Cysview. Cystview is the latest development to cystoscopes that aids in better diagnosis of bladder cancer thereby catalyzing the cystoscopes market. Industrial players namely Olympus Corporation and Karl Storz GmbH & Co. KG have adopted the BLC technique ensuring steady growth of this market.

Of the products types offered by various market players, video cystoscopes accounted for maximum market share in 2017. The advent of BLC technique, easy to use attribute, better imaging & diagnostic features and cost-efficiency primarily contributed to the increasing demand for video cystoscopes. The demand for non-video cystoscopes yet exists among hospitals or clinics with low budget requirements. Hospitals form the primary end users for cystoscopes indicating maximum market share in 2017. The reason for this attributed to its developed healthcare infrastructure, high disposable income, presence of skilled professionals and availability of desired sterile conditions.

The cystoscopes market has gained extensive market attraction across the globe owing to its enhanced diagnostic properties along with growing prevalence of bladder cancer that increases the demand for the same. Of the geographies analyzed, North America accounted for maximum market share in 2017 and expected to continue similar trends through 2026 as well. Continuously growing economy, high disposable income of people, well-structured healthcare policies and constant research activities primarily drives North Americas’ cystoscopes market.

The global cystoscopes market encompasses extensive competitive pool comprising market leaders such as Cogentix Medical, Inc., Henke Sass Wolf GmbH, Fujifilm Corporation, Karl Storz GmbH & Co. KG, Maxer Endoscopy GmbH, Laborie Medical Technologies, Inc., Medline Industries, Inc., PENTAX Medical Company, Olympus Corporation, Stryker Corporation and Richard Wolf GmbH.

Key Market Movements:

  • Global cystoscopes market experienced steady growth with a CAGR of 6.9% during the forecast period from 2018 to 2026
  • Increase in prevalence of kidney stones & bladder cancer along with the growing awareness of cystoscopes accounts to steady growth of this market
  • Of the end users, hospitals dominated the market owing to their developed infrastructure, availability of skilled professionals and increased patient trust on hospital procedures
  • Video cystoscopes accounted for maximum market share in 2017 and expected to maintain similar trends through 2026 as well

Browse Full Report With TOC, Figures And Tables @ http://www.credenceresearch.com/report/cystoscopes-market

Related Reports:

Ultrafast CT Scan Devices Market

Direct-To-Consumer (DTC) Genetic Testing Market

Orthopedic Prosthetic Devices Market

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact:

Name: Chris Smith

Designation : Global Sales Manager

E-mail : sales@credenceresearch.com

Ph : + 1-800-361-8290

Connect With US:

Web:   Credence Research

Facebook @ https://www.facebook.com/CredenceResearch

Twitter @ https://twitter.com/CredenceResearc

Linkedin @ h ttps://us.linkedin.com/company/credenceresearch

G+ @ https://plus.google.com/+Credenceresearch

Our Blog: http://www.mobilecomputingtoday.co.uk/7750/cy...-research/

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 35

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 19

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 47

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 31

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 26

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 37

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 29

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

ConocoPhillips Prepares for Third Quarter Earnings Report

Updated Category News Views 132

ConocoPhillips Earnings Preview ConocoPhillips (NYSE: COP) is set to unveil its earnings results for the third quarter, drawing significant attention from investors and analysts alike. This report is expected to be released before the opening bell on the designated Thursday. Analysts project that ConocoPhillips will report earnings of $1.41 per share, a decrease from...

Continue Reading
Tesla's FSD Ambitions Shine Amid Market Uncertainty

Updated Category News Views 138

Tesla's Ambitious Goals for Full Self-Driving Technology Tesla, Inc. TSLA is pursuing an ambitious plan to introduce its groundbreaking full self-driving (FSD) technology to markets around the world, with a particular focus on regions in Asia and Europe. What to Anticipate from Tesla's FSD Launch Industry expert Greg Migliore, editor-in-chief of Real Auto Blog, bel

Continue Reading
Centners Pursue $885M Defamation Case Against Local Newspaper

Updated Category News Views 230

Centners File Major Defamation Lawsuit Against a Newspaper Philanthropists and entrepreneurs David and Leila Centner have taken a significant step by initiating a defamation lawsuit against a prominent newspaper and several journalists. They are asserting that the newspaper has intentionally misrepresented public records regarding their generous donation intentions aimed...

Continue Reading
NACCO Industries Reports Solid Performance Amid Challenges

Updated Category News Views 140

NACCO Industries Announces Second Quarter Results NACCO Industries, Inc. (NYSE: NC) has revealed its consolidated results for the three and six months ending in June 2025. The company faced some short-term operational challenges, impacting their ability to meet expected growth targets. Despite this setback, NACCO's versatile sectors remain primed for recovery and...

Continue Reading
Unlocking Income: Earning $500 Monthly from Jefferies Stock

Updated Category News Views 100

Understanding Jefferies Financial Group Inc. Jefferies Financial Group Inc. (NYSE: JEF) is a key player in the financial services sector, known for its robust investment banking operations and diverse financial solutions. With the company's upcoming earnings report for the fourth quarter, there’s excitement surrounding its performance and future potential. Although the...

Continue Reading